Merck's Exit Highlights UK Risks Losing Pharma Investment Amid Rising Costs

benzinga.com/markets/large-cap/25/09/47650124/merck-exit-highlights-uk-risks-losing-pharma-investment-amid-rising-costs

The U.K. faces a growing risk of losing pharmaceutical investment. That’s according to Oxford professor John Bell, a scientist who was involved in coordinating government and industry efforts during the COVID-19 vaccine rollout.
His remarks come after the U.S. drugmaker Merck & Co. Inc.…

This story appeared on benzinga.com, 2025-09-12 18:21:07.
The Entire Business World on a Single Page. Free to Use →